Phase 2B/3 Double-blinded Placebo-controlled

Clinical trial NCT03107377 · COMPLETED

Trial details

NCT number: NCT03107377
Sponsor: Evofem Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Chlamydia Trachomatis Infection

Start date: 2017-11-03
Primary completion: 2019-08-22
Enrollment: 860

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.